More about

Endometrial Cancer

News
July 25, 2024
2 min watch
Save

VIDEO: Significant need for better patient education in endometrial cancer

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about better patient education in endometrial cancer patients.

News
July 25, 2024
2 min watch
Save

VIDEO: Racial disparities in access to care, diagnostic delay in endometrial cancer

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about racial disparities in endometrial cancer.

News
July 25, 2024
2 min watch
Save

VIDEO: Addressing obesity in endometrial cancer patients who want to have children

  Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about obesity in endometrial cancer patients.

News
July 22, 2024
2 min watch
Save

VIDEO: Precision medicine, diagnosis management, other advancements in endometrial cancer

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about recent advancements in endometrial cancer care.

News
July 11, 2024
2 min read
Save

Top in women’s health: Racial disparities in cancer detection, early death rates

Rates of early death from gynecologic cancers were higher among Black women compared with women of other races and ethnicities, recent data show.

News
July 10, 2024
4 min read
Save

Shared decision-making critical for managing polycystic ovary syndrome

Polycystic ovary syndrome presents in many forms with many manifestations, which is why providers must work with patients to treat the condition while factoring in their preferences and top concerns.

News
July 03, 2024
2 min read
Save

Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women

Transvaginal ultrasonography triage resulted in misclassification for more than one in 10 Black women, suggesting it is not a reliable strategy to identify Black women at risk for endometrial cancer, according to a diagnostic study.

News
June 18, 2024
2 min read
Save

FDA approves Imfinzi regimen for advanced endometrial cancer

The FDA approved the use of durvalumab in combination with carboplatin and paclitaxel followed by single-agent durvalumab for women with mismatch repair-deficient primary advanced or recurrent endometrial cancer.

News
June 07, 2024
3 min read
Save

American Indian, Native Hawaiian data ‘effectively nonexistent’ in cancer trials

Most phase 2/phase 3 oncology clinical trials do not report American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander racial categories in their studies, according to findings published in JAMA Health Forum.

News
May 24, 2024
3 min read
Save

Type of menopausal hormone therapy may influence cancer risk

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.

View more